Alliancebernstein L.P. Aspira Women'S Health Inc. Transaction History

Alliancebernstein L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.4 - $1.09 $27,560 - $75,101	-68,900 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$0.88 - $1.81 $4,048 - $8,326	-4,600 Reduced 6.26%	68,900 $72,000
Q2 2021 Jul 30, 2021	BUY	$4.78 - $6.84 $39,196 - $56,088	8,200 Added 12.56%	73,500 $413,000
Q1 2021 May 06, 2021	SELL	$5.9 - $9.13 $37,760 - $58,432	-6,400 Reduced 8.93%	65,300 $441,000
Q4 2020 Feb 08, 2021	BUY	$3.0 - $6.71 $16,800 - $37,576	5,600 Added 8.47%	71,700 $481,000
Q2 2020 Aug 13, 2020	BUY	$0.78 - $5.25 $51,558 - $347,025	66,100 New	66,100 $254,000

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $123M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.